Jonathan W. Paschal
Eli Lilly and Company
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jonathan W. Paschal.
Tetrahedron Letters | 1991
Herbert A. Kirst; Karl H. Michel; James W. Martin; Lawrence Creemer; Eddie H. Chio; Raymond C. Yao; Walter Mitsuo Nakatsukasa; Laverne Dwaine Boeck; John L. Occolowitz; Jonathan W. Paschal; Jack B. Deeter; Noel D. Jones; Gary D. Thompson
Abstract A multi-factored complex of structurally-unique macrolides was isolated from culture broths of a new species of Saccharopolyspora. The core structure consists of a 5,6,5-cis-anti-trans-tricyclic ring system fused to a 12-membered macrocyclic lactone, which is further substituted by an amino- and a neutral sugar.
Bioorganic & Medicinal Chemistry Letters | 1995
Bryan H. Norman; Jonathan W. Paschal; Chris J. Vlahos
Abstract Synthetic studies on the fungal metabolite, wortmannin, were undertaken in an effort to gain insight into the structure activity relationships of wortmannin analogs on phosphatidylinositol-3′-kinase (PI-3-kinase). Our work has focused on the chemistry of the previously unexplored furan ring and has uncovered several interesting and novel chemical transformations, which are described herein.
Tetrahedron Letters | 1993
Jack B. Deeter; David Hall; Christopher L. Jordan; Richard M. Justice; Michael Dean Kinnick; John M. Morin; Jonathan W. Paschal; Robert L. Ternansky
Abstract A new method for the synthesis of chiral azetidinones bearing a carbon-carbon bond at the 4-position is described. The preparation involves a stereoselective alkylation-reduction of a silylated 4-phenylsulfonyl azetidinone. The utility of this method was demonstrated by a formal total synthesis of loracarbef.
Bioorganic & Medicinal Chemistry Letters | 2000
Yan-Zhi Zhang; Robert Boyer; Xicheng Sun; Jonathan W. Paschal; Shu-Hui Chen
The syntheses and preliminary investigation of antifungal activities of two dehydro PSB derivatives 8 and 10 as well as one 3-imido-9-dechloro PSB analogue 13 are described.
Bioorganic & Medicinal Chemistry Letters | 2000
Shu-Hui Chen; Xicheng Sun; Robert Boyer; Jonathan W. Paschal; Doug Zeckner; William L. Current; Mark J. Zweifel; Michael J. Rodriguez
A series of aliphatic side-chain analogues of pseudomycin was synthesized and evaluated during the course of our side-chain SAR effort. We found that several of the pseudomycin side-chain analogues (e.g., 10) exhibited good in vitro activity against all three major fungi responsible for systemic fungal infections.
Tetrahedron Letters | 1996
David Andrew Neel; Richard Elmer Holmes; Jonathan W. Paschal
The synthesis of bicyclic pyrazolidinone 2 is described. Traditional methods for penem and cephem ring cyclization were found to be unsuccessful and new methodology using a Curtius rearrangement was utilized. The 3-enamine 11 was hydrolysed to the desired β-keto ester 2b without substantial loss of the t-BOC protecting group.
Journal of Organic Chemistry | 1990
Robert Theodore Shuman; Paul L. Ornstein; Jonathan W. Paschal; Paul David Gesellchen
Journal of Medicinal Chemistry | 1991
Paul L. Ornstein; Darryle D. Schoepp; Macklin Brian Arnold; Leander Jd; David Lodge; Jonathan W. Paschal; T. Elzey
Journal of Medicinal Chemistry | 1996
James A. Monn; Matthew John Valli; Bryan G. Johnson; Craig R. Salhoff; Rebecca A. Wright; Trevor J. Howe; Ann Bond; David Lodge; Larry A. Spangle; Jonathan W. Paschal; Jack B. Campbell; Kelly I. Griffey; Joseph P. Tizzano; Darryle D. Schoepp
Journal of Medicinal Chemistry | 1989
Paul L. Ornstein; Schaus Jm; Chambers Jw; Huser Dl; Leander Jd; Wong Dt; Jonathan W. Paschal; Noel D. Jones; Deeter Jb